Articles

Published on 22 August 2019

2019/2 GaBI Journal Table of Contents

Contents Editor’s Letter Unmet potential of Generics and Biosimilars to reduce healthcare costs Original Research Pricing of oral generic cancer medicines in 25 European countries; findings and implications Review Article...

2.226 views

Read more →

Legal

Published on 21 August 2019

Policy recommendations for a sustainable biosimilars market: lessons from Europe

Author byline as per print journal: Professor Philip J Schneider1, MS, FASHP, FASPEN, FFIP; Michael S Reilly2, Esq Abstract: Approximately 25% of all new medicines approved in recent years and...

Author(s): Michael S Reilly, Esq, Professor Philip J Schneider, MS, FASHP, FASPEN, FFIP

biologicals/biosimilars, competition, patients, procurement, substitution, sustainability

DOI: 10.5639/gabij.2020.0902.013

17.337 views

Read more →

Editor's Letter

Published on 14 August 2019

Unmet potential of Generics and Biosimilars to reduce healthcare costs

The high cost of pharmaceuticals has been gaining increasing attention as a threat to both healthcare systems and patients’ access to care globally. This GaBI issue contains articles focusing on...

Author(s): Professor Philip D Walson, MD

DOI: 10.5639/gabij.2019.0802.006

3.536 views

Read more →

Published on 29 May 2019

2019/1 GaBI Journal Table of Contents

Contents Editor’s Letter Editor’s introduction to the initial issue of the eighth volume of GaBI Journal Legal Biosimilars: considerations in light of the Italian legal framework Special Report Patent expiry...

2.366 views

Read more →

Editor's Letter

Published on 29 May 2019

Editor’s introduction to the initial issue of the eighth volume of GaBI Journal

This issue contains important information and manuscripts, but the small number of original papers illustrates the challenge the GaBI Journal (as well as many other legitimate journals) is having attracting...

Author(s): Professor Philip D Walson, MD

DOI: 10.5639/gabij.2019.0801.001

2.653 views

Read more →

Abstracted Scientific Content

Published on 29 May 2019

Regulatory requirements for the acceptance of foreign comparator products in the participants of the International Generic Drug Regulators Programme

Submitted: 4 March 2019; Revised: 25 April 2019; Accepted: 27 April 2019; Published online first: 30 April 2019 The availability of quality generic drug products plays an increasingly important role...

Author(s): Alfredo García Arieta, PhD

DOI: 10.5639/gabij.2019.0801.005

15.293 views

Read more →

Pharma News

Published on 21 May 2019

Top developments in biosimilars during 2018

Submitted: 5 February 2019; Revised: 14 March 2019; Accepted: 20 March 2019; Published online first: 2 April 2019 The global market for biosimilars is valued at approximately US$4 billion, and...

Author(s): GaBI Journal Editor

DOI: 10.5639/gabij.2019.0801.004

8.693 views

Read more →

Published on 28 January 2019

2018/4 GaBI Journal Table of Contents

Contents Editor’s Letter Fourth and final issue of GaBI Journal’s seventh volume Editorial Nomenclature for biosimilars; a continuing thorny issue Original Research Ongoing activities to influence the prescribing of proton...

2.547 views

Read more →

Editor's Letter

Published on 28 January 2019

Fourth and final issue of GaBI Journal’s seventh volume

Globalization of the world’s economy has clearly created both major advances and ongoing challenges including in the pharmaceutical industry. Naming of pharmaceuticals might seem to be an uninteresting topic to...

Author(s): Professor Philip D Walson, MD

DOI: 10.5639/gabij.2018.0704.028

2.829 views

Read more →

Published on 07 January 2019

2018/3 GaBI Journal Table of Contents

Contents Editor’s Letter Latest features in GaBI Journal, 2018, Issue 3 Commentary Medicines regulation in the MENA region and the importance of the World Health Organization’s INN proposal of Biological...

2.266 views

Read more →

Abstracted Scientific Content

Published on 19 December 2018

US generic prescription drug markets 2004‒2016

Submitted: 6 December 2018; Revised: 12 December 2018; Accepted: 14 December 2018; Published online first: 19 December 2018 Generic drugs are currently central to disease treatment in the US. However,...

Author(s): GaBI Journal Editor

DOI: 10.5639/gabij.2018.0704.033

6.263 views

Read more →

Abstracted Scientific Content

Published on 03 December 2018

How does generic drug policy affect market prices?

Submitted: 21 November 2018; Revised: 22 November 2018; Accepted: 28 November 2018; Published online first: 4 December 2018 A study published by the World Health Organization (WHO) compares the effect...

Author(s): GaBI Journal Editor

DOI: 10.5639/gabij.2018.0703.027

5.139 views

Read more →